TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 DKK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover | 4,289 | 4,160 | 3,539 |
Financial expenses | 0 | 241 | 4 |
Earnings before taxes | 2,978 | 2,576 | 2,440 |
EBITDA | 2,717 | 1,345 | 2,380 |
Total assets | 14,428 | 12,404 | 9,926 |
Current assets | 5,622 | 5,403 | 3,377 |
Current liabilities | 1,857 | 1,306 | 564 |
Equity capital | 12,357 | 10,466 | 8,770 |
- share capital | 32 | 34 | 36 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency | 85.6% | 84.4% | 88.4% |
Turnover per employee | 2,144 | 2,080 | 1,770 |
Profit as a percentage of turnover | 69.4% | 61.9% | 68.9% |
Return on assets (ROA) | 20.6% | 22.7% | 24.6% |
Current ratio | 302.7% | 413.7% | 598.8% |
Return on equity (ROE) | 24.1% | 24.6% | 27.8% |
Change turnover | 326 | 853 | 182 |
Change turnover % | 8% | 26% | 5% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.